ECMO in Myocardial Infarction-Associated Cardiogenic Shock: Blood Biomarkers as Predictors of Mortality.

Diagnostics (Basel) · 2023 · PMC10742636 · PMID 38132267

Europe PMC DOI

hedged sentences

0.7080

closest p · 14.2× alpha

0.7080

boldest claim

The sentences

did not reach statistical significancep = 0.708not close (p > 0.1)

Finally, deceased patients experienced sepsis more often compared with survivors, even though this did not reach statistical significance (19.3% vs. 17%, p = 0.708).

also in 111,027 other papers

showed a trendno p-value reported

In cases of adverse events, bleeding events during ECMO showed a trend toward increased mortality ( Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.